Christopher B. Hansen
( out of 1234 reviews )

Christopher B. Hansen, MD

Languages spoken: English, French

Clinical Locations

Midvalley Health Center Dermatology

Dermatology
Murray
801-581-2955
Directions

  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 1234 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 25, 2025
    MIDVALLEY

    Dr Hansen is the best! Kind, calm, and informative.

    January 24, 2025
    MIDVALLEY

    Dr Hansen and his Student were very thorough in their examination. Dr Hansen's communication was clear and instructions were very good.

    January 23, 2025
    MIDVALLEY

    Perfection !

    January 20, 2025
    MIDVALLEY

    Great care and concern.

    January 17, 2025
    MIDVALLEY

    Doctor Hansen is personable and happy to meet with you. He even remembered it was my birthday He takes such good care of my skin cancer. Listens when I'm concerned about something on my skin..and reassures me. We love going to his office!

    January 17, 2025
    MIDVALLEY

    Very personable and an excellent provider.

    January 16, 2025
    MIDVALLEY

    Very professional and thorough

    January 16, 2025
    MIDVALLEY

    Dr. Christopher B. Hansen & the other staff where very welcoming, knowledgable & professional. He listened to my concerns & provided options for care and I was able to choose what best suited my needs. I would highly recommend!

    January 16, 2025
    MIDVALLEY

    Dr. Hansen is the very best! I really appreciate his approach and thoroughness. Great interaction.

  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Board Certification and Academic Information

    Academic Departments Dermatology -Associate Professor (Clinical)
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Chief Resident Dermatology - University of Texas Southwestern Chief Resident
    Residency Dermatology - University of Texas Southwestern Medical School Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Research Fellow Dermatology - University of Utah - Dermatology Research Fellow
    Professional Medical Medicine - University of Utah M.D.
    Undergraduate French - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Sahni V, Teames C, Seifert R, Conley M, deShazo R, Powell D, Rhoads JLW, Clarke JT, Hansen CB, Zone JJ, Hull CM, Hopkins ZH (2025). The association between skin allergy testing and oral squamous cell carcinoma in oral lichen planus: a retrospective cohort study. Arch Dermatol Res, 317(1), 207. (Read full article)
    2. Esquivel ACF, Hansen CB (2024). Neurosensory symptoms and muscle cramping in morphea: A cross-sectional study and review. Skin Health Dis, 4(6), e453. (Read full article)
    3. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2024). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    4. Marcelus C, Jimenez A, Zussman J, Hansen CB, Sontheimer RD (2022). Questions raised by a case of adult-onset linear nodular scleroderma. Dermatol Online J, 28(5). (Read full article)
    5. Overbury RS, Stoddard GJ, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (2021). The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle. BMC Health Serv Res, 21(1), 913. (Read full article)
    6. Beshay A, Zussman J, Hansen C (2020). Recurrent erythematous patch on the upper arm. JAAD Case Rep, 6(12), 1214-1216. (Read full article)
    7. Winchester D, Duffin KC, Hansen C (2012). Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus, 21(9), 1007-10. (Read full article)
    8. Hansen CB, Dahle KW (2012). Cutaneous lupus erythematosus. Dermatol Ther, 25(2), 99-111. (Read full article)
    9. Gammon B, Hansen C, Costner MI (2011). Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. J Am Acad Dermatol, 65(4), 717-721.e2. (Read full article)
    10. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD (2011). A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol, 164(3), 465-72. (Read full article)
    11. Hansen CB, Callen JP (2010). Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther, 23(4), 341-9. (Read full article)

    Case Report

    1. Shah A, Bowen A, Hansen C (2020). Multifocal periungual granulation tissue related to ibrutinib therapy. JAAD Case Rep, 6(2), 149-151. (Read full article)

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
    2. Gonzalez CD, Hansen C, Clarke JT (2019). Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. [Letter to the editor]. J Am Acad Dermatol, 81(3), 859-860. (Read full article)